Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: COPD
Age: Adults
Condition: Maintenance therapy
Dose: Convicap – 200 mcg
Frequency: 2 capsules twice daily
Indication: COPD
Age: Adults
Condition: Maintenance therapy
Dose: Convicap – 400 mcg
Frequency: 1 capsule twice daily

Child Dose

Clinical InformationAdministration Information
Age: less than 12 years
Dose: Not applicable
Note: Safety and efficacy not established
Indication: COPD
Age: 12 years and older
Condition: Maintenance therapy
Dose: Convicap – 200 mcg
Frequency: 2 Convicaps twice daily

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment
Dose: Budesonide + Formoterol Fumarate
Note: Formal pharmacokinetic studies using Budesonide + Formoterol Fumarate have not been conducted in patients with renal impairment.
Administration
  • Can be taken with or without food
  • Shake inhaler well before each use
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP3A4 inhibitors
May inhibit metabolism of budesonide
Non Potassium-sparing diuretics (Amiloride, Eplerenone, Spironolactone, Triamterene)
May lead to ECG changes and/or hypokalaemia

Disease Interaction

Disease NameRisk Factors
Status Asthmaticus, Acute Episodes of Asthma
Not suitable for emergency treatment

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Protect from light, store in cool & dry place. Do not store above 30° C. Keep out of the reach of children. Protect from freezing.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.